2 Beaten-Down Growth Stocks to Buy Hand Over Fist

September wasn't a great month on Wall Street. The S&P 500 dropped almost 5%, and plenty of stocks performed significantly worse. For instance, shares of biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) fell about 8% while cloud computing company Veeva Systems (NYSE: VEEV) saw its stock plunge nearly 14%. 

But if you intend to hold the shares of companies for five years or more -- which is a smart strategy for generating above-average returns -- then a single month's results will merely amount to a blip in your portfolio's performance. And over the long haul, both Vertex and Veeva have what it takes to beat the market despite their recent poor performance.

Continue reading

Source Fool.com